Latest News

GeoVax Announces Upcoming Presentation of Lassa Fever Vaccine Data
ATLANTA, GA, July 16, 2019 – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company specializing i...
Continue Reading...
GeoVax to Conduct Partnering Meetings During BIO International Convention June 3-6, 2019
GeoVax Selected by NIH and BIO to Showcase its Technology as Part of the BIO Innovation Zone ATLANT...
Continue Reading...
GeoVax Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11
Recognizing the Support of the National Institutes of Health and the HIV Vaccine Trials Networkin ...
Continue Reading...